Exelixis
EXEL
#1806
Rank
$11.17 B
Marketcap
$41.67
Share price
-0.38%
Change (1 day)
12.56%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company